The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Standard Treatment Regimens for Nongonococcal Urethritis Have Similar but Declining Cure Rates: A Randomized Controlled Trial
Open accessAbstract
BACKGROUND: Azithromycin or doxycycline is recommended for nongonococcal urethritis (NGU); recent evidence suggests their efficacy has declined. We compared azithromycin and doxycycline in men with NGU, hypothesizing that azithromycin was more effective than doxycycline. METHODS: From January 2007 to July 2011, English-speaking males ≥16 years, attending a sexually transmitted diseases clinic in Seattle, Washington, with NGU (visible urethral discharge or ≥5 polymorphonuclear leukocytes per high-power field [PMNs/HPF]) were eligible for this double-blind, parallel-group superiority trial. Participants received active azithromycin (1 g) + placebo doxycycline or active doxycycline (100 mg twice daily for 7 days) + placebo azithromycin. Urine was tested for Chlamydia trachomatis (CT), Mycoplasma genitalium (MG), Ureaplasma urealyticum biovar 2 (UU-2), and Trichomonas vaginalis (TV) using nucleic acid amplification tests. Clinical cure (<5 PMNs/HPF with or without urethral symptoms and absence of discharge) and microbiologic cure (negative tests for CT, MG, and/or UU-2) were determined after 3 weeks. RESULTS: Of 606 men, 304 were randomized to azithromycin and 302 to doxycycline; CT, MG, TV, and UU-2 were detected in 24%, 13%, 2%, and 23%, respectively. In modified intent-to-treat analyses, 172 of 216 (80%; 95% confidence interval [CI], 74%-85%) receiving azithromycin and 157 of 206 (76%; 95% CI, 70%-82%) receiving doxycycline experienced clinical cure (P = .40). In pathogen-specific analyses, clinical cure did not differ by arm, nor did microbiologic cure differ for CT (86% vs 90%, P = .56), MG (40% vs 30%, P = .41), or UU-2 (75% vs 70%, P = .50). No unexpected adverse events occurred. CONCLUSIONS: Clinical and microbiologic cure rates for NGU were somewhat low and there was no significant difference between azithromycin and doxycycline. Mycoplasma genitalium treatment failure was extremely common. Clinical Trials Registration.NCT00358462.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Less common causes include Trichomonas vaginalis (TV), herpes simplex virus (HSV), and adenovirus [1, 5, 7, 10, 11].”
From Urethral Microbiota in Men: Association of Haemophilus influenzae and Mycoplasma penetrans With Nongonococcal Urethritis (2021) · cites this paper as [7]
In the citing paper
“Among studies investigating whether bacteria other than CT and MG are associated with NGU, several have evaluated the role of Ureaplasma urealyticum (UU), but results have been inconsistent [1, 7, 12-14].”
From Urethral Microbiota in Men: Association of Haemophilus influenzae and Mycoplasma penetrans With Nongonococcal Urethritis (2021) · cites this paper as [7]
In the citing paper
“Emerging evidence suggests differences in etiology among men who have sex with men (MSM) and men who have sex with women (MSW) [5, 7, 8].”
From Urethral Microbiota in Men: Association of Haemophilus influenzae and Mycoplasma penetrans With Nongonococcal Urethritis (2021) · cites this paper as [7]
In the citing paper
“The most common cause of NGU is Chlamydia trachomatis (CT), accounting for 20% to 40% of NGU cases [5-8].”
From Urethral Microbiota in Men: Association of Haemophilus influenzae and Mycoplasma penetrans With Nongonococcal Urethritis (2021) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Cited by
Sexually transmitted diseases treatment guidelines (2015)
Workowski, K., & BOLAN, G. A. (2015) · Reproductive Endocrinology · doi:10.18370/2309-4117.2015.24.51-56 · Cited by 2,698
Sexually Transmitted Diseases Treatment Guidelines, 2010
(2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.04.006 · Cited by 2,076
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Workowski, K. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ771 · Cited by 588
Mycoplasma genitalium Infection and Female Reproductive Tract Disease: A Meta-analysis
Lis, R., Rowhani-Rahbar, A., & Manhart, L. E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ312 · Cited by 460
Self-citation2016 European guideline on Mycoplasma genitalium infections
Jensen, J. S., Cusini, M., Gomberg, M., & Moi, H. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13849 · Cited by 343
2021 European guideline on the management of Mycoplasma genitalium infections
Jensen, J. S., Cusini, M., Gomberg, M., Moi, H., Wilson, J., & Unemo, M. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17972 · Cited by 255
Read, T. R. H., Fairley, C. K., Murray, G. L., Jensen, J. S., Danielewski, J., Worthington, K., Doyle, M., Mokany, E., Tan, L., Chow, E. P. F., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy477 · Cited by 216
Pond, M. J., Nori, A. V., Witney, A. A., Lopeman, R. C., Butcher, P. D., & Sadiq, S. T. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit752 · Cited by 184
Guschin, A., Ryzhikh, P., Rumyantseva, T., Gomberg, M., & Unemo, M. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0781-7 · Cited by 97
Srinivasan, S., Chambers, L. C., Tapia, K. A., Hoffman, N. G., Munch, M. M., Morgan, J. L., Domogala, D., Sylvan Lowens, M., Proll, S., Huang, M.-L., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1123 · Cited by 73
Self-citationBarbee, L. A., Khosropour, C. M., Dombrowski, J. C., Manhart, L. E., & Golden, M. R. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052214 · Cited by 72
Self-citationAntibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women
Páez-Canro, C., Alzate, J. P., González, L. M., Rubio-Romero, J. A., Lethaby, A., & Gaitán, H. G. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010871.pub2 · Cited by 42
Crofts, M., Blee, K., Evans, C., Tipple, C., Rayment, M., & Horner, P. J. (2026) · International Journal of STD & AIDS · doi:10.1177/09564624261430584 · Cited by 3
Metadata
- Authors
- Manhart, L. E., Gillespie, C. W., Lowens, M. S., Khosropour, C. M., Colombara, D. V., Golden, M. R., Hakhu, N. R., Thomas, K. K., Hughes, J. P., Jensen, N. L., & Totten, P. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-12-07
- Volume
- 56
- Issue
- 7
- Pages
- 934-942
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2164950865
- Cited by
- 203
- References
- 1
- FWCI
- 17.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.